Ernexa Therapeutics
ERNA----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Ernexa Therapeutics(ERNA) predict that the EBIT is -5.59 M (--%), Miss estimate;the EPS is -6.95 (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.01B--
-0.00B--
-0.00B--%
EPSMiss expectations
-6.95--
-1.95--
-5.0000--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf